{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:54:01Z","timestamp":1782489241488,"version":"3.54.5"},"reference-count":28,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"unspecified","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013953","name":"Maccabi Institute for Health Services Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013953","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterise post-stroke depression (PSD) diagnostic and treatment patterns in an outpatient primary care setting, including timing, screening methods, therapeutic interventions and associations with mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Maccabi Healthcare Services, the second largest Healthcare Maintenance Organisation in Israel, covering more than 2.7\u2009million citizens between 2016 and 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Participants were adult patients with a new stroke diagnosis between 2016 and 2022\u2009and a subsequent diagnosis of depression according to International Classification of Diseases clinical criteria or antidepressant medication initiation. Patients with a diagnosis of depression or antidepressant treatment prior to stroke were excluded from the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcomes<\/jats:title>\n                    <jats:p>Primary outcomes included PSD diagnosis rates, time to diagnosis and treatment, use of screening questionnaires, specialty of the physician making the diagnosis and all-cause mortality. Secondary outcomes included referral rates to mental health services, rehabilitation participation and its impact on mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 11\u2009499 patients, PSD occurred in 4620 (40.2%) patients. Primary care physicians diagnosed 53.1% of cases based on clinical assessment; only 4.5% of patients underwent Patient Health Questionnaire-2 screening. Most diagnoses occurred in the first year (53.4%). Antidepressants, predominantly selective serotonin reuptake inhibitors (58.3%), were initiated within 30 days in 65.1% of diagnosed patients. Patients with PSD demonstrated higher rehabilitation participation (69.5% vs 48.5%, p&lt;0.001) and paradoxically lower mortality rates (22.1% vs 27.9%, p&lt;0.001). Patients without PSD were older with a greater comorbidity burden. Cox regression identified physiotherapy visits (HR=0.625, p&lt;0.001) and mental health consultations (HR=0.642, p&lt;0.001) as protective factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this cohort, in an outpatient primary care setting, primary care physicians diagnosed the majority of PSD cases, predominantly relying on clinical criteria, without using screening tools. The majority of PSD diagnoses occurred during the first year after stroke (53.1%), suggesting that repeated evaluation might be appropriate during this follow-up period. Early antidepressant treatment and enhanced rehabilitation engagement may positively influence mortality outcomes in patients with PSD. Low utilisation of standard screening tools and mental health referrals represents an area for potential improvement in PSD management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116795","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:01:03Z","timestamp":1777910463000},"page":"e116795","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Post-stroke depression management in the Israeli primary care setting: a retrospective cohort study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5015-1554","authenticated-orcid":false,"given":"Olga","family":"Spivak","sequence":"first","affiliation":[{"name":"Family Medicine Department, Maccabi Healthcare Services, Tel Aviv-Yafo, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Lev-Shalem","sequence":"additional","affiliation":[{"name":"Family Medicine Department, Maccabi Healthcare Services, Tel Aviv-Yafo, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomit","family":"Yaari","sequence":"additional","affiliation":[{"name":"Family Medicine Department, Maccabi Healthcare Services, Tel Aviv-Yafo, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-6596","authenticated-orcid":false,"given":"Limor","family":"Adler","sequence":"additional","affiliation":[{"name":"Family Medicine Department, Maccabi Healthcare Services, Tel Aviv-Yafo, Israel"},{"name":"Family Medicine, Tel Aviv University Faculty of Medical and Health Sciences, Tel Aviv-Yafo, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"2026062608312081000_16.5.e116795.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2020.06.011"},{"key":"2026062608312081000_16.5.e116795.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10597-4"},{"key":"2026062608312081000_16.5.e116795.3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5694\/mja2.51256","article-title":"Screening for post-stroke depression: who, when and how?","volume":"215","author":"Sewell","year":"2021","journal-title":"Med J Aust"},{"key":"2026062608312081000_16.5.e116795.4","first-page":"81","article-title":"PREDICTORS OF EARLY-ONSET DEPRESSION AFTER FIRST-EVER STROKE","volume":"59","author":"Rabi-\u017diki\u0107","year":"2020","journal-title":"Acta Clin Croat"},{"key":"2026062608312081000_16.5.e116795.5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s11606-011-1709-6","article-title":"Pre-post evaluation of automated reminders may improve detection and management of post-stroke depression","volume":"26","author":"Williams","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2026062608312081000_16.5.e116795.6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s11065-023-09611-5","article-title":"Comparing the Symptomatology of Post-stroke Depression with Depression in the General Population: A Systematic Review","volume":"34","author":"Blake","year":"2024","journal-title":"Neuropsychol Rev"},{"key":"2026062608312081000_16.5.e116795.7","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1212\/WNL.0000000000001029","article-title":"Explanatory factors for the increased mortality of stroke patients with depression","volume":"83","author":"Ayerbe","year":"2014","journal-title":"Neurology (ECronicon)"},{"key":"2026062608312081000_16.5.e116795.8","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000257319.14023.61"},{"key":"2026062608312081000_16.5.e116795.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.10.035"},{"key":"2026062608312081000_16.5.e116795.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-020-02699-6","article-title":"The validity and reliability of the PHQ-9 in screening for post-stroke depression","volume":"20","author":"Dajpratham","year":"2020","journal-title":"BMC Psychiatry"},{"key":"2026062608312081000_16.5.e116795.11","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.070281"},{"key":"2026062608312081000_16.5.e116795.12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/10749357.2018.1536096","article-title":"Screening Adherence for Depression Post Stroke: Evaluation of Outpatients, a London Experience (SAD PEOPLE)","volume":"26","author":"MacKenzie","year":"2019","journal-title":"Top Stroke Rehabil"},{"key":"2026062608312081000_16.5.e116795.13","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000113"},{"key":"2026062608312081000_16.5.e116795.14","doi-asserted-by":"publisher","DOI":"10.1177\/1747493019847334"},{"key":"2026062608312081000_16.5.e116795.15","unstructured":"Bowen AJM , Young G . National clinical guideline for stroke: Royal College of Physicians, 2016. Available: https:\/\/www.strokeguideline.org\/app\/uploads\/2023\/03\/2016-National-Clinical-Guideline-for-Stroke-5th-edition.pdf [Accessed 21 Mar 2026]."},{"key":"2026062608312081000_16.5.e116795.16","unstructured":"Kuniavsky M , Bronstein O , Konson A , et al . The Israeli National Program for Quality Indicators for General and Geriatric Hospitals, Psychiatric Hospitals, Mother & Baby Health Centers and Emergency Medical Services (Ambulances), 2025. Available: https:\/\/www.gov.il\/BlobFolder\/reports\/quality-national-prog-2013-2024\/he\/files_publications_quality_indicators_quality-national-prog-2013-2024.pdf"},{"key":"2026062608312081000_16.5.e116795.17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cnc.2022.11.002","article-title":"Stroke Rehabilitation","volume":"35","author":"Neil","year":"2023","journal-title":"Crit Care Nurs Clin North Am"},{"key":"2026062608312081000_16.5.e116795.18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245912","article-title":"Selective Serotonin Reuptake Inhibitors for the Prevention of Post-Stroke Depression: A Systematic Review and Meta-Analysis","volume":"10","author":"Richter","year":"2021","journal-title":"J Clin Med"},{"key":"2026062608312081000_16.5.e116795.19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/YIC.0000000000000532","article-title":"A comprehensive overview of post-stroke depression treatment options","volume":"39","author":"Raggi","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"key":"2026062608312081000_16.5.e116795.20","doi-asserted-by":"crossref","first-page":"107292","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107292","article-title":"A systematic review and evaluation of post-stroke depression clinical practice guidelines","volume":"32","author":"Cross","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026062608312081000_16.5.e116795.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294668","article-title":"Impact of depression on stroke outcomes among stroke survivors: Systematic review and meta-analysis","volume":"18","author":"Shewangizaw","year":"2023","journal-title":"PLoS One"},{"key":"2026062608312081000_16.5.e116795.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2008.07.010"},{"key":"2026062608312081000_16.5.e116795.23","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.14.5.736"},{"key":"2026062608312081000_16.5.e116795.24","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.158.1.83"},{"key":"2026062608312081000_16.5.e116795.25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/brain\/107.1.81","article-title":"Mood disorders in stroke patients. Importance of location of lesion","volume":"107 (Pt 1)","author":"Robinson","year":"1984","journal-title":"Brain (Bacau)"},{"key":"2026062608312081000_16.5.e116795.26","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/25.6.479"},{"key":"2026062608312081000_16.5.e116795.27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2017.11.005","article-title":"Post-stroke depression: Mechanisms and pharmacological treatment","volume":"184","author":"Villa","year":"2018","journal-title":"Pharmacol Ther"},{"key":"2026062608312081000_16.5.e116795.28","article-title":"Antidepressants for depression in people with physical illness","volume":"2000","author":"Gill","year":"2000","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:39:45Z","timestamp":1782488385000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,4]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2026-116795"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116795","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}